Inventor · disambiguated record
Allen Borchardt
Also filed as: BORCHARDT ALLEN · BORCHARDT ALLEN J · BORCHARDT ALLEN JOHN
18 granted patents·19 pending applications·795 citations·filing 2001–2022
95Inventor score
Top patents by PatentIndex Score
37 records- 0198US6884890B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted Apr 26, 2005·178 cites·32 claims
- 0298US6534524B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2001·Granted Mar 18, 2003·277 cites·14 claims
- 0396US6531491B1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARAMACEUTICALS INC·Filed 2001·Granted Mar 11, 2003·200 cites·10 claims
- 0492US8080566B1Carbazole inhibitors of histamine receptors for the treatment of diseaseKAHRAMAN MEHMET·Filed 2009·Granted Dec 20, 2011·14 cites·10 claims
- 0591US6891044B2Indazole compounds and pharmaceutical compositions for Inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 10, 2005·20 cites·43 claims
- 0690US11833213B2Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Granted Dec 5, 2023·3 cites·10 claims
- 0790US7141587B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2004·Granted Nov 28, 2006·17 cites·9 claims
- 0888US11510992B1Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Granted Nov 29, 2022·2 cites·35 claims
- 0987US6620828B2Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their useAGOURON PHARMA·Filed 2001·Granted Sep 16, 2003·45 cites·13 claims
- 1084US8569300B2Substituted tetrazolo[1,5-A]pyrazine inhibitors of histamine receptors for the treatment of diseaseBORCHARDT ALLEN·Filed 2011·Granted Oct 29, 2013·14 cites·17 claims
- 1181US7053107B2Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2003·Granted May 30, 2006·12 cites·4 claims
- 1276US6878727B2Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the sameAGOURON PHARMA·Filed 2003·Granted Apr 12, 2005·11 cites·9 claims
- 1375US12427200B2Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2022·Granted Sep 30, 2025·0 cites·20 claims
- 1471US10385055B2Tricyclic gyrase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Aug 20, 2019·2 cites·16 claims
- 1563US2021220478A1Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1663US2021228727A1Compositions and methods for the treatment of viral infectionsCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1759US2010120741A1Heterocyclic inhibitors of histamine receptors for the treatment of diseaseKALYPSYS INC·Filed 2009·Application pending·0 cites
- 1858US7473790B2Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the samePFIZER·Filed 2006·Granted Jan 6, 2009·0 cites·18 claims
- 1956US2024024497A1Methods for the synthesis of protein-drug conjugatesCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2056US2023364251A1Methods for the synthesis of protein-drug conjugatesCIDARA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2156US2009318485A1Novel inhibitors of rho kinaseKALYPSYS INC·Filed 2007·Application pending·0 cites
- 2255US7148226B2Inhibitors of hepatitis C virus RNA-dependent RNA polymerase, and compositions and treatments using the sameAGOURON PHARMA·Filed 2003·Granted Dec 12, 2006·0 cites·28 claims
- 2354US2004224960A1Pharmaceutical compositions and methods for their useAGOURON PHARMA·Filed 2004·Application pending·0 cites
- 2453US2008021026A1Benzothiophene inhibitors of rho kinaseKAHRAMAN MEHMET·Filed 2007·Application pending·0 cites
- 2553US2008021217A1Heterocyclic inhibitors of rho kinaseBORCHARDT ALLEN J·Filed 2007·Application pending·0 cites
- 2652US2006252807A1Novel ortho-terphenyl inhibitors of p38 kinase and methods of treating inflammatory disordersKALYPSYS INC·Filed 2006·Application pending·0 cites
- 2751US2006160858A1Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their useAGOURON PHARMA·Filed 2005·Application pending·0 cites
- 2851US2010063047A1Aminopyrimidine inhibitors of histamine receptors for the treatment of diseaseKALYPSYS INC·Filed 2009·Application pending·0 cites
- 2950US7115658B2Inhibitors of hepatitis C virus RNA-dependent RNA polymeraseAGOURON PHARMA·Filed 2003·Granted Oct 3, 2006·0 cites·2 claims
- 3049US2023079107A1Compositions and methods for the treatment of human immunodeficiency virusCIDARA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3149US2023082611A1Compositions and methods for the treatment of respiratory syncytial virusCIDARA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 3247US2023165970A1Compositions and methods for the treatment of bacterial infectionsCIDARA THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3345US2012065187A1Heterocyclic inhibitors of histamine receptors for the treatment of diseaseBORCHARDT ALLEN J·Filed 2011·Application pending·0 cites
- 3444US10865216B2Tricyclic Gyrase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Dec 15, 2020·0 cites·16 claims
- 3544US2023190950A1Compositions and methods for the treatment of bacterial infectionsCIDARA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 3636US2011237599A1Heterocyclic inhibitors of histamine receptors for the treatment of diseaseKALYPSYS INC·Filed 2011·Application pending·0 cites
- 3734US2011257137A1Heterocyclic inhibitors of histamine receptors for the treatment of diseaseKALYPSYS INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Allen Borchardt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →